CSRxP has launched a national campaign as part of a multi-million-dollar effort to hold Big Pharma accountable for their out-of-control prescription drug prices. Because Big Pharma blocks competition to maintain monopolies on medicines, they can set any price they want.
“Big Pharma’s longstanding pattern of utilizing the REMS process to forestall generic and biosimilar medications from reaching patients is an anticompetitive and cynical abuse of an important tool for patient safety.”
“The FAST Generics Act represents market-based reforms that will increase competition and ensure that lifesaving medications can safely reach patients at an affordable price.”
American Academy of Family Physicians Joins CSRxP The Campaign for Sustainable Rx Pricing (CSRxP) today announced that the American Academy of Family Physicians (AAFP) joined the Campaign. Founded 70 years ago, the AAFP represents 124,900 physicians and medical students nationwide, and is the only medical society devoted solely to primary care. AAFP joins a broad-based campaign that includes […]
“We must ‘bring down the artificially high price of drugs and bring them down immediately.’ That’s what the President said in his address to Congress – and the American people agree.
We applaud President Trump for making the out-of-control prices of prescription drugs a priority in his Administration.
“No amount of advertising will make hardworking families forget the consequences of their out-of-control drug costs.”
A new HHS Office of the Inspector General report finds that high-priced prescription drugs are threatening the sustainability of the taxpayer-funded Medicare Part D program.
Based on Novo Nordisk’s announcement, it is clear that the company will continue to hike insulin prices, despite the financial burdens already facing patients. “The prescription drug market is clearly broken when limiting yearly price increases to ten percent is considered bighearted,” said John Rother.
“We are encouraged to see the president-elect is ready to take action. We look forward to working with the new Administration and the new Congress to find solutions to fix the broken prescription drug market, and to help make life-saving medications more affordable for the patients who need them.”